Vimarsana
Biggest News Aggregation in the World

C Plasma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from C Plasma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In C Plasma Today - Breaking & Trending Today

Kirin's LC-Plasma sales held up in spring and summer as it strives to "make immune care a habit" - Vimarsana News

Kirin's LC-Plasma sales held up in spring and summer as it strives to "make immune care a habit"

Kirin says that revenue from LC-Plasma, its flagship immune health ingredient, has grown significantly even during spring and summer this year, although these are seasons when consumers tend to take fewer precautions against infectious diseases.

Blackmores eyes market boost in China and NPD with Kirin's flagship ingredients - Vimarsana News

Blackmores eyes market boost in China and NPD with Kirin's flagship ingredients

Blackmores is set to ramp up advertising to boost brand awareness in China and Indonesia, while also formulating new products with Kirin’s ingredients post the Japanese giants acquisition of the firm.

Latest scientific findings on EPA, tocopherol, and updates on New Zealand's diet study - Vimarsana News

Latest scientific findings on EPA, tocopherol, and updates on New Zealand's diet study

This round-up looks at the latest findings from health and nutrition research, including the benefit of eicosapentaenoic acid (EPA) in lowering cardiovascular disease risk among diabetic patients, γ-tocopherol in reducing premenstrual symptoms such as water retention, and updates on New Zealand’s study on the effects of locally produced food and beverages in improving cardiometabolic health.

Kirin to double down on immunity beverage range as sales surge in Q1 - Vimarsana News

Kirin to double down on immunity beverage range as sales surge in Q1

Kirin says that functional drinks from its health science domain are the “particular focus” for its beverage business this year after sales of its LC-Plasma immunity range increased by 8.5 per cent to 1.71 million cases in Q1.